CRISPR Therapeutics GAAP EPS of -$1.37 misses by $0.22, revenue of $0.86M misses by $3.16M [Seeking Alpha]
CRISPR Therapeutics AG - Common Shares (CRSP)
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
nasdaq.com/symbol/crsp/real-time
Company Research
Source: Seeking Alpha
Cash Position: Cash, cash equivalents, and marketable securities were $1,975.8 million as of December 31, 2025, compared to $1,903.8 million as of December 31, 2024. Newsletters for Every Investor Get daily, sector-specific newsletters packed with expert insights, fresh ideas, and new opportunities. Subscribe to Newsletters Sign Up More on CRISPR Therapeutics Crispr Therapeutics: Patience And Opportunity Through Volatility 44th Annual J.P. Morgan Healthcare Conference CRISPR Therapeutics AG (CRSP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Insider trades: Merck, Intel, Micron among notable names Crispr Therapeutics pares loss amid takeover speculation Recommended For You
Show less
Read more
Impact Snapshot
Event Time:
CRSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRSP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRSP alerts
High impacting CRISPR Therapeutics AG - Common Shares news events
Weekly update
A roundup of the hottest topics
CRSP
News
- CRISPR Therapeutics (NASDAQ:CRSP) had its "outperform" rating reaffirmed by analysts at Evercore ISI.MarketBeat
- CRISPR Therapeutics (NASDAQ:CRSP) had its "hold" rating reaffirmed by analysts at TD Cowen.MarketBeat
- CRISPR Therapeutics (NASDAQ:CRSP) had its price target raised by analysts at Needham & Company LLC from $80.00 to $82.00. They now have a "buy" rating on the stock.MarketBeat
- CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewswire
- Studies test whether gene-editing can fix high cholesterol. For now, take your medicine [Yahoo! Finance Canada]Yahoo! Finance Canada
CRSP
Earnings
- 2/12/26 - Miss
CRSP
Sec Filings
- 2/12/26 - Form 10-K
- 2/12/26 - Form 8-K
- 2/5/26 - Form SCHEDULE
- CRSP's page on the SEC website